Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study

Objectives: We aimed to evaluate the drug retention rate and safety of secukinumab (SEC) in patients with axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA) in a real clinical setting. Methods: This multicenter retrospective observational study included all AxSpA and PsA patients who rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso, Sara, Villa, Ignacio, Fernández, Sabela, Martín, José L., Charca, Lilyan, Pino, Marina, Riancho, Leyre, Morante, Isla, Santos, Monserrat, Brandy, Anahy, Aurrecoechea, Elena, Carmona, Loreto, Queiro, Rubén
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187784/
https://www.ncbi.nlm.nih.gov/pubmed/34124110
http://dx.doi.org/10.3389/fmed.2021.679009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187784/
https://www.ncbi.nlm.nih.gov/pubmed/34124110
http://dx.doi.org/10.3389/fmed.2021.679009

Ejemplares similares